| TKL Ser/Thr protein kinase family |
|---|
|
| Symbol | TKL |
|---|
| Membranome | 1216 |
|---|
Bone morphogenetic protein receptors are serine-threonine kinase receptors. Transforming growth factor beta family proteins bind to these receptors.[1] There are four bone morphogenetic protein receptors:[2]
- Bone morphogenetic protein receptor, type 1:
- Bone morphogenetic protein receptor, type 2
Structure
Both type 1 and 2 bone morphogenetic protein receptors have a single transmembrane segment. Additionally, both types have a cysteine-rich extracellular domain and a cytoplasmic serine threonine kinase domain.[3] Type 1 contains a glycine-serine-rich domain to be phosphorylated by type 2 kinase domain, initiating the signaling transduction pathway of the SMAD signaling cascade.[3] The wrist epitope motif on BMP-2 has a high-affinity binding site for BMPR-IA. The knuckle epitope motif on BMP-2 has a low-affinity binding site for BMPR-II.[4]
See also
- Bone morphogenetic protein
References
- ^ Miyazono K, Kamiya Y, Morikawa M (January 2010). "Bone morphogenetic protein receptors and signal transduction". Journal of Biochemistry. 147 (1): 35–51. doi:10.1093/jb/mvp148. PMID 19762341.
- ^ Pasche B (December 2008). "The TGF Family. Cold Spring Harbor Monograph Series, Volume 50. Edited by Rik Derynck, Kohei Miyazono. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. xiv-1114 p.; ill.; index. 9780879697525. 2008". The Quarterly Review of Biology. 83 (4): 405–405. doi:10.1086/596254.
- ^ a b Mace PD, Cutfield JF, Cutfield SM (December 2006). "High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding". Biochemical and Biophysical Research Communications. 351 (4): 831–8. doi:10.1016/j.bbrc.2006.10.109. PMID 17094948.
- ^ Miyazono K, Shimanuki T (January 2008). "Chapter 55: Bone morphogenetic protein receptors and actions.". In Bilezikian JP, Raisz LG, Martin TJ (eds.). Principles of bone biology (Third ed.). San Diego: Academic Press. pp. 1177–1196. doi:10.1016/B978-0-12-373884-4.00069-0. ISBN 978-0-12-373884-4.
External links
|
|---|
| Type I cytokine receptor |
- Nerve growth factors: Ciliary neurotrophic factor
- Erythropoietin
|
|---|
| Receptor protein serine/threonine kinase | |
|---|
| Receptor tyrosine kinase | |
- Nerve growth factors: high affinity Trk
| |
- Somatomedin
- Insulin-like growth factor 1
|
- ErbB/Epidermal growth factor
| |
|
|---|
| Tumor necrosis factor receptor |
- Nerve growth factors: Low affinity/p75
|
|---|
| Ig superfamily |
- Platelet-derived growth factor
- Stem cell factor
|
|---|
| Other/ungrouped |
- Somatomedin
- Insulin-like growth factor 2
|
|---|
|
|---|
| TGF beta superfamily of ligands | | Ligand of ACVR or TGFBR | |
|---|
| Ligand of |
- Bone morphogenetic proteins
- BMP2
- BMP3
- BMP4
- BMP5
- BMP6
- BMP7
- BMP8a
- BMP8b
- BMP10
- BMP15
- Growth differentiation factors
- GDF1
- GDF2
- GDF3
- GDF5
- GDF6
- GDF7
- Myostatin/GDF8
- GDF9
- GDF10
- GDF11
- GDF15
- Anti-müllerian hormone
|
|---|
|
|---|
TGF beta receptors (Activin, BMP, family) | | TGFBR1: |
- Activin type 1 receptors
- ACVRL1
- BMPR1
|
|---|
| TGFBR2: |
- Activin type 2 receptors
- AMHR2
- BMPR2
|
|---|
| TGFBR3: | |
|---|
|
|---|
| Transducers/SMAD |
- R-SMAD (SMAD1
- SMAD2
- SMAD3
- SMAD5
- SMAD9)
- I-SMAD (SMAD6
- SMAD7)
- SMAD4
|
|---|
| Ligand inhibitors |
- Cerberus
- Chordin
- Decorin
- Follistatin
- Gremlin
- Lefty
- LTBP1
- Noggin
- PARN
- THBS1
|
|---|
| Coreceptors | |
|---|
| Other | |
|---|
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12) |
|---|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20) |
|---|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30) |
|---|
| Polo kinase (EC 2.7.11.21) | |
|---|
| Cyclin-dependent kinase (EC 2.7.11.22) |
- CDK1
- CDK2
- CDKL2
- CDK3
- CDK4
- CDK5
- CDKL5
- CDK6
- CDK7
- CDK8
- CDK9
- CDK10
- CDK12
- CDC2L5
- PCTK1
- PCTK2
- PCTK3
- PFTK1
- CDC2L1
|
|---|
| (RNA-polymerase)-subunit kinase (EC 2.7.11.23) |
- RPS6KA5
- RPS6KA4
- P70S6 kinase
- P70-S6 Kinase 1
- RPS6KB2
- RPS6KA2
- RPS6KA3
- RPS6KA1
- RPS6KC1
|
|---|
| Mitogen-activated protein kinase (EC 2.7.11.24) |
- Extracellular signal-regulated
- MAPK1
- MAPK3
- MAPK4
- MAPK6
- MAPK7
- MAPK12
- MAPK15
- C-Jun N-terminal
- P38 mitogen-activated protein
|
|---|
| MAP3K (EC 2.7.11.25) |
- MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
- RAFs
- MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
- MAP3K14
|
|---|
| Tau-protein kinase (EC 2.7.11.26) | |
|---|
| (acetyl-CoA carboxylase) kinase (EC 2.7.11.27) | |
|---|
| Tropomyosin kinase (EC 2.7.11.28) | |
|---|
| Low-density-lipoprotein receptor kinase (EC 2.7.11.29) | |
|---|
| Receptor protein serine/threonine kinase (EC 2.7.11.30) | |
|---|
|
|
Dual-specificity kinases (EC 2.7.12) |
|---|
| MAP2K |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
|---|
|
|
Enzymes |
|---|
| Activity |
- Active site
- Binding site
- Catalytic triad
- Oxyanion hole
- Enzyme promiscuity
- Diffusion-limited enzyme
- Cofactor
- Enzyme catalysis
|
|---|
| Regulation | |
|---|
| Classification |
- EC number
- Enzyme superfamily
- Enzyme family
- List of enzymes
|
|---|
| Kinetics |
- Enzyme kinetics
- Eadie–Hofstee diagram
- Hanes–Woolf plot
- Lineweaver–Burk plot
- Michaelis–Menten kinetics
|
|---|
| Types |
- EC1 Oxidoreductases (list)
- EC2 Transferases (list)
- EC3 Hydrolases (list)
- EC4 Lyases (list)
- EC5 Isomerases (list)
- EC6 Ligases (list)
- EC7 Translocases (list)
|
|---|
|
|---|
| Type I | | ALK1 (ACVRL1) |
- Agonists: Activin (A, B, AB)
- Avotermin
- BMP (10)
- Cetermin
- GDF (2 (BMP9))
- TGFβ (1, 2, 3)
- Kinase inhibitors: K-02288
- ML-347 (LDN-193719, VU0469381)
- Other inhibitors: Disitertide
|
|---|
| ALK2 (ACVR1A) |
- Agonists: Activin (A, B, AB)
- AMH (MIS)
- Avotermin
- BMP (5, 6, 7, 8A, 8B)
- Eptotermin alfa
- TGFβ (1, 2, 3)
- Kinase inhibitors: DMH-1
- DMH-2
- Dorsomorphin (BML-275)
- K-02288
- ML-347 (LDN-193719, VU0469381)
|
|---|
| ALK3 (BMPR1A) |
- Agonists: AMH (MIS)
- BMP (2, 4, 5, 6, 7, 8A, 8B)
- Dibotermin alfa
- Eptotermin alfa
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
|---|
| ALK4 (ACVR1B) |
- Agonists: Activin (A, B, AB)
- GDF (1, 3, 11 (BMP11))
- Myostatin (GDF8)
- Nodal
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
|---|
| ALK5 (TGFβR1) |
- Agonists: Avotermin
- GDF (10 (BMP3B), 11 (BMP11))
- TGFβ (1, 2, 3)
|
|---|
| ALK6 (BMPR1B) |
- Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
- Radotermin
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
|---|
| ALK7 (ACVR1C) |
- Agonists: GDF (1, 3, 11 (BMP11))
- Nodal
- Antagonists: Lefty (1, 2)
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
|---|
|
|---|
| Type II | | TGFβR2 |
- Agonists: Avotermin
- GDF (10 (BMP3B))
- TGFβ (1, 2, 3)
- Kinase inhibitors: DMH-2
- LY-364947
|
|---|
| BMPR2 |
- Agonists: BMP (2, 4, 6, 7, 10)
- Dibotermin alfa
- Eptotermin alfa
- GDF (2 (BMP9), 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Radotermin
|
|---|
| ACVR2A (ACVR2) |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
- Myostatin (GDF8)
- Nodal
- Radotermin
|
|---|
| ACVR2B |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 6, 7)
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Myostatin (GDF8)
- Nodal
- Osteogenin (BMP3, BMP3A)
- Radotermin
- Decoy receptors: Ramatercept
|
|---|
| AMHR2 (AMHR) | |
|---|
|
|---|
| Type III | |
|---|
| Unsorted |
- Endogenous antagonists/inhibitors: BAMBI
- Cerberus (CER1)
- Chordin
- DAN (PARN)
- Decorin
- Follistatin
- Gremlin (Drm)
- LTBP1
- Noggin
- TGIF
- Thrombospondin 1 (THBS1)
- Tomoregulin 1
- Antibodies: Stamulumab (against myostatin)
- TRC105 (against endoglin)
|
|---|